Delivery Order SPE2DB20D2014-SPE2DB25FB26R

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,959.56, is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract is a firm-fixed-price arrangement with a completion date of June 28, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $9,254.29, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed-price arrangement. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,512.50, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of January 28, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order valued at $10,432.55, is for the supply of Ozempic 0.25-0.5 mg/dose pens with a completion date of February 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,829.39, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of November 21, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,294.61, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of November 20, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,044.01, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 9, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,451.30, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,831.71, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed price delivery order. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,245.18, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL dosage. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB26R
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 ml). The contract, valued at $3,006.54, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price arrangement with a period of performance ending on March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/6/25, 10:08 AM